Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)

Clinical trial NCT06060652 · UNKNOWN

Trial details

NCT number: NCT06060652
Sponsor: Centro di Riferimento Oncologico - Aviano
Status: UNKNOWN
Study type: OBSERVATIONAL

Oligometastatic Prostate Cancer

Start date: 2023-05-11
Primary completion: 2026-05-11
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.